Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 10 of 10 entries
View as:

Cross-sectional Study to Assess Prevalence and Burden of CKD-associated Pruritus in Haemodialysis Patients

Phase: N/A Priority: Normal
NCT ID: NCT05524467 Org: User:
Start: 02/02/23 End: 01/31/24 Due: 01/31/25

Cross-sectional Study to Assess Prevalence and Burden of CKD-associated Pruritus in Hemodialysis Patients

Phase: N/A Priority: Normal
NCT ID: NCT05625542 Org: User:
Start: 06/10/23 End: 06/30/23 Due: 06/30/24

RAYALDEE Non Interventional Study (NIS) on Effectiveness in ND-CKD SHPT Patients

Phase: N/A Priority: Normal
NCT ID: NCT05460234 Org: User:
Start: 10/05/22 End: 09/30/25 Due: 09/30/26

Cardiovascular and Renal Treatment in Heart Failure Patients With Hyperkalaemia or at High Risk of Hyperkalaemia

Phase: N/A Priority: Normal
NCT ID: NCT04864795 Org: User:
Start: 04/19/21 End: 08/30/24 Due: 08/30/25

Study to Compare Ferric Carboxymaltose With Placebo in Patients With Acute Heart Failure and Iron Deficiency

Phase: N/A Priority: Normal
NCT ID: NCT02937454 Org: User:
Start: 04/03/17 End: 07/21/20 Due: 07/21/21

Study to Assess Efficacy and Safety of VIT-2763 (Vamifeport) in Subjects With Sickle Cell Disease

Phase: N/A Priority: Normal
NCT ID: NCT04817670 Org: User:
Start: 11/18/21 End: 03/07/24 Due: 03/07/25

To Assess the Impact of Ferric Carboxymaltose Compared With Iron Sucrose in Chinese Subjects on Correcting Iron Deficiency Anaemia

Phase: N/A Priority: Normal
NCT ID: NCT03591406 Org: User:
Start: 07/03/17 End: 02/25/19 Due: 02/25/20

Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Preliminary Efficacy of VIT-2763 in β-thalassaemia

Phase: N/A Priority: Normal
NCT ID: NCT04364269 Org: User:
Start: 06/11/20 End: 11/03/21 Due: 11/03/22

Efficacy and Safety Study of Multiple Doses of VIT-2763 in Adults With Transfusion-dependent Beta-thalassemia

Phase: N/A Priority: Normal
NCT ID: NCT04938635 Org: User:
Start: 09/20/21 End: 07/31/23 Due: 07/31/24

Bioavailability Study Comparing 2 Vamifeport Oral Formulations in Fasted Versus Fed State in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT05077436 Org: User:
Start: 10/14/21 End: 01/05/22 Due: 01/05/23